Literature DB >> 24687855

Unraveling the complexities of DNA-dependent protein kinase autophosphorylation.

Jessica A Neal1, Seiji Sugiman-Marangos2, Pamela VanderVere-Carozza3, Mike Wagner4, John Turchi5, Susan P Lees-Miller6, Murray S Junop2, Katheryn Meek7.   

Abstract

DNA-dependent protein kinase (DNA-PK) orchestrates DNA repair by regulating access to breaks through autophosphorylations within two clusters of sites (ABCDE and PQR). Blocking ABCDE phosphorylation (by alanine mutation) imparts a dominant negative effect, rendering cells hypersensitive to agents that cause DNA double-strand breaks. Here, a mutational approach is used to address the mechanistic basis of this dominant negative effect. Blocking ABCDE phosphorylation hypersensitizes cells to most types of DNA damage (base damage, cross-links, breaks, and damage induced by replication stress), suggesting that DNA-PK binds DNA ends that result from many DNA lesions and that blocking ABCDE phosphorylation sequesters these DNA ends from other repair pathways. This dominant negative effect requires DNA-PK's catalytic activity, as well as phosphorylation of multiple (non-ABCDE) DNA-PK catalytic subunit (DNA-PKcs) sites. PSIPRED analysis indicates that the ABCDE sites are located in the only contiguous extended region of this huge protein that is predicted to be disordered, suggesting a regulatory role(s) and perhaps explaining the large impact ABCDE phosphorylation has on the enzyme's function. Moreover, additional sites in this disordered region contribute to the ABCDE cluster. These data, coupled with recent structural data, suggest a model whereby early phosphorylations promote initiation of nonhomologous end joining (NHEJ), whereas ABCDE phosphorylations, potentially located in a "hinge" region between the two domains, lead to regulated conformational changes that initially promote NHEJ and eventually disengage NHEJ.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24687855      PMCID: PMC4054291          DOI: 10.1128/MCB.01554-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

1.  The PSIPRED protein structure prediction server.

Authors:  L J McGuffin; K Bryson; D T Jones
Journal:  Bioinformatics       Date:  2000-04       Impact factor: 6.937

2.  Pathways of DNA double-strand break repair during the mammalian cell cycle.

Authors:  Kai Rothkamm; Ines Krüger; Larry H Thompson; Markus Löbrich
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

3.  Both V(D)J recombination and radioresistance require DNA-PK kinase activity, though minimal levels suffice for V(D)J recombination.

Authors:  L J Kienker; E K Shin; K Meek
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

4.  Ataxia telangiectasia mutated (ATM) is essential for DNA-PKcs phosphorylations at the Thr-2609 cluster upon DNA double strand break.

Authors:  Benjamin P C Chen; Naoya Uematsu; Junya Kobayashi; Yaniv Lerenthal; Andrea Krempler; Hirohiko Yajima; Markus Löbrich; Yosef Shiloh; David J Chen
Journal:  J Biol Chem       Date:  2006-12-21       Impact factor: 5.157

5.  trans Autophosphorylation at DNA-dependent protein kinase's two major autophosphorylation site clusters facilitates end processing but not end joining.

Authors:  Katheryn Meek; Pauline Douglas; Xiaoping Cui; Qi Ding; Susan P Lees-Miller
Journal:  Mol Cell Biol       Date:  2007-03-12       Impact factor: 4.272

6.  Severe combined immunodeficient cells expressing mutant hRAD54 exhibit a marked DNA double-strand break repair and error-prone chromosome repair defect.

Authors:  J M Pluth; L M Fried; C U Kirchgessner
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

7.  Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks.

Authors:  Doug W Chan; Benjamin Ping-Chi Chen; Sheela Prithivirajsingh; Akihiro Kurimasa; Michael D Story; Jun Qin; David J Chen
Journal:  Genes Dev       Date:  2002-09-15       Impact factor: 11.361

8.  Threonines 2638/2647 in DNA-PK are essential for cellular resistance to ionizing radiation.

Authors:  Sébastien Soubeyrand; Louise Pope; Benjamin Pakuts; Robert J G Haché
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

9.  Autophosphorylation of the catalytic subunit of the DNA-dependent protein kinase is required for efficient end processing during DNA double-strand break repair.

Authors:  Qi Ding; Yeturu V R Reddy; Wei Wang; Timothy Woods; Pauline Douglas; Dale A Ramsden; Susan P Lees-Miller; Katheryn Meek
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

10.  Identification of in vitro and in vivo phosphorylation sites in the catalytic subunit of the DNA-dependent protein kinase.

Authors:  Pauline Douglas; Gopal P Sapkota; Nick Morrice; Yaping Yu; Aaron A Goodarzi; Dennis Merkle; Katheryn Meek; Dario R Alessi; Susan P Lees-Miller
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

View more
  31 in total

1.  Deciphering phenotypic variance in different models of DNA-PKcs deficiency.

Authors:  Jessica A Neal; Katheryn Meek
Journal:  DNA Repair (Amst)       Date:  2018-10-30

2.  Noncoding RNA joins Ku and DNA-PKcs for DNA-break resistance in breast cancer.

Authors:  Susan P Lees-Miller; Tara L Beattie; John A Tainer
Journal:  Nat Struct Mol Biol       Date:  2016-06-07       Impact factor: 15.369

3.  Regulation of human polλ by ATM-mediated phosphorylation during non-homologous end joining.

Authors:  Guillermo Sastre-Moreno; John M Pryor; Marta Moreno-Oñate; Andrés M Herrero-Ruiz; Felipe Cortés-Ledesma; Luis Blanco; Dale A Ramsden; Jose F Ruiz
Journal:  DNA Repair (Amst)       Date:  2017-01-17

4.  The novel, small-molecule DNA methylation inhibitor SGI-110 as an ovarian cancer chemosensitizer.

Authors:  Fang Fang; Joanne Munck; Jessica Tang; Pietro Taverna; Yinu Wang; David F B Miller; Jay Pilrose; Gavin Choy; Mohammad Azab; Katherine S Pawelczak; Pamela VanderVere-Carozza; Michael Wagner; John Lyons; Daniela Matei; John J Turchi; Kenneth P Nephew
Journal:  Clin Cancer Res       Date:  2014-10-14       Impact factor: 12.531

5.  Restoration of ATM Expression in DNA-PKcs-Deficient Cells Inhibits Signal End Joining.

Authors:  Jessica A Neal; Yao Xu; Masumi Abe; Eric Hendrickson; Katheryn Meek
Journal:  J Immunol       Date:  2016-02-26       Impact factor: 5.422

6.  XRCC4/XLF Interaction Is Variably Required for DNA Repair and Is Not Required for Ligase IV Stimulation.

Authors:  Sunetra Roy; Abinadabe J de Melo; Yao Xu; Satish K Tadi; Aurélie Négrel; Eric Hendrickson; Mauro Modesti; Katheryn Meek
Journal:  Mol Cell Biol       Date:  2015-06-22       Impact factor: 4.272

7.  The TMPRSS2-ERG Gene Fusion Blocks XRCC4-Mediated Nonhomologous End-Joining Repair and Radiosensitizes Prostate Cancer Cells to PARP Inhibition.

Authors:  Payel Chatterjee; Gaurav S Choudhary; Turkeyah Alswillah; Xiahui Xiong; Warren D Heston; Cristina Magi-Galluzzi; Junran Zhang; Eric A Klein; Alexandru Almasan
Journal:  Mol Cancer Ther       Date:  2015-05-29       Impact factor: 6.261

8.  The Human T-Cell Leukemia Virus Type 1 Basic Leucine Zipper Factor Attenuates Repair of Double-Stranded DNA Breaks via Nonhomologous End Joining.

Authors:  Amanda W Rushing; Kimson Hoang; Nicholas Polakowski; Isabelle Lemasson
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

9.  Deciphering the role of distinct DNA-PK phosphorylations at collapsed replication forks.

Authors:  Jessica A Neal; Krista Dunger; Kelly Geith; Katheryn Meek
Journal:  DNA Repair (Amst)       Date:  2020-07-08

10.  DNA-PKcs and PARP1 Bind to Unresected Stalled DNA Replication Forks Where They Recruit XRCC1 to Mediate Repair.

Authors:  Songmin Ying; Zhihui Chen; Annette L Medhurst; Jessica A Neal; Zhengqiang Bao; Oliver Mortusewicz; Joanna McGouran; Xinming Song; Huahao Shen; Freddie C Hamdy; Benedikt M Kessler; Katheryn Meek; Thomas Helleday
Journal:  Cancer Res       Date:  2015-11-24       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.